2Nofech-Mozes Y,Garty BZ.Thrombocytopenia in Kawasaki disease:a risk factor for the development of coronary artery aneurysms[J].Pediatr Hematol Oncol,2003,20(8):597-601.
3Oki I,Tanihara S,Ojima T,et al.A multicenter collaborative study on the risk factors of cardiac sequelae due to Kawasaki disease:a one-year follow-up study[J].Acta Paediatr,2000,89(12):1435-1438.
4Nakamura Y,Yashiro M,Uehara R,et al.Use of laboratory data to identify risk factor of giant coronary aneurysms due to Kawasaki disease[J].Pediatr Int,2004,46(1):33-38.
5Suzuki Y,Iijima M,Sasaki H,et al.Tachycardia as a potential risk indicator for coronary arterial lesions in Kawasaki disease[J].Eur J Pediatr,1999,158(3):207-209.
6Kim M,Kim K.Elevation of cardiac troponin I in the acute stage of Kawasaki disease[J].Pediatr Cardiol,1999,20(3):184-188.
7Checchia PA,Borensaajn J,Shulman ST.Circulating cardiac troponin I levels in Kawasaki disease[J].Pediatr Cardiol,2001,22(2):102-106.
8Kawamura T,Wago M,Kawaguchi H,et al.Plasma brain natriuretic peptide concentration in patients with Kawasaki disease[J].Pediatr Int,2000,42(3):241-248.
9Terai M,Shulman ST.Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose[J].J Pediatr,1997,131(6):888-893.
